These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16176226)

  • 1. Management of elderly patients with breast cancer: the time for surgery.
    Rai S; Stotter A
    ANZ J Surg; 2005 Oct; 75(10):863-5. PubMed ID: 16176226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.
    Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M
    Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
    Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16. Breast cancer in older women.
    Bultitude MF; Fentiman IS
    Int J Clin Pract; 2002 Oct; 56(8):588-90. PubMed ID: 12425368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?].
    Sanguinetti A; Ragusa M; De Falco M; Sperlongano P; Calzolari F; Parmeggiani D; Misso C; Piatto A; Parmeggiani U; Avenia N
    Chir Ital; 2007; 59(6):829-33. PubMed ID: 18360988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.
    Rao VS; Jameel JK; Mahapatra TK; McManus PL; Fox JN; Drew PJ
    Breast J; 2007; 13(4):368-73. PubMed ID: 17593041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trends in breast cancer treatment in the elderly at a breast cancer outpatient clinic: guidelines followed better].
    Hamaker ME; Schreurs WH; van Slooten HJ; Uppelschoten JM; Smorenburg CH
    Ned Tijdschr Geneeskd; 2009; 153():A562. PubMed ID: 19930741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of tamoxifen in pT1a-pT1b, pN0 breast cancer.
    Livi L; Saieva C; Paiar F; Simontacchi G; Galardi A; De Luca Cardillo C; Mangoni M; Paoletti L; Ponticelli P; Biti GP
    Eur J Surg Oncol; 2007 Apr; 33(3):271-5. PubMed ID: 16831531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence, indications and outcome for the non-operative management of breast cancer.
    Atkin GK; Scott MA; Wiggins JE; Callam MJ
    J Surg Oncol; 2007 Aug; 96(2):137-43. PubMed ID: 17443721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
    Alkner S; Bendahl PO; Fernö M; Nordenskjöld B; Rydén L;
    Eur J Cancer; 2009 Sep; 45(14):2496-502. PubMed ID: 19535242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
    Lash TL; Gurwitz JH; Silliman RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
    Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
    Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.
    Freedman GM; Anderson P; Li T; Ross E; Swaby R; Goldstein L
    Cancer; 2006 Dec; 107(11):2552-8. PubMed ID: 17061250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.